<DOC>
	<DOCNO>NCT00622102</DOCNO>
	<brief_summary>We perform research study learn control individual 's blood thinning ( anticoagulation ) warfarin . Individuals anticoagulation clinic ask participate order see lottery provide opportunity win money combination use Med-eMonitor might useful help patient achieve good control anticoagulation therapy . Half participant enrol lottery arm half control group receive Med-eMonitor .</brief_summary>
	<brief_title>Testing Strategies Improving Warfarin Adherence</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>21 year old age old On warfarin manage AC clinic Target INR 2.03.0 2.53.5 At maintenance phase therapy ( define stable INR stable warfarin dose least 2 consecutive visit ) Do access telephone line Unwillingness participate sign consent form ( refusal ) Inability participate advance dementia , advance Alzheimer 's disease impairment affect ability provide inform consent and/or quality data utilize MedeMonitor Participation current study permit participation another study End stage terminal illness anticipate life expectancy 6 month less INR upper limit individual 's range time enrollment ( e.g. , &gt; 3.0 &gt; 3.5 , depend target range ) Diagnosed antiphospholipid antibody syndrome abnormal INR prior start warfarin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>warfarin</keyword>
	<keyword>adherence</keyword>
	<keyword>Mechanical heart valve</keyword>
</DOC>